| 000 | 01293 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250515023405.0 | ||
| 264 | 0 | _c20060711 | |
| 008 | 200607s 0 0 eng d | ||
| 022 | _a0889-8529 | ||
| 024 | 7 |
_a10.1016/j.ecl.2006.02.012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiddle, Rodger A | |
| 245 | 0 | 0 |
_aPathophysiology of SPINK mutations in pancreatic development and disease. _h[electronic resource] |
| 260 |
_bEndocrinology and metabolism clinics of North America _cJun 2006 |
||
| 300 |
_a345-56, x p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCarrier Proteins _xgenetics |
| 650 | 0 | 4 |
_aCystic Fibrosis Transmembrane Conductance Regulator _xgenetics |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aPancreatitis _xenzymology |
| 650 | 0 | 4 | _aPoint Mutation |
| 650 | 0 | 4 | _aTrypsin Inhibitor, Kazal Pancreatic |
| 650 | 0 | 4 |
_aTrypsinogen _xmetabolism |
| 773 | 0 |
_tEndocrinology and metabolism clinics of North America _gvol. 35 _gno. 2 _gp. 345-56, x |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ecl.2006.02.012 _zAvailable from publisher's website |
| 999 |
_c16235846 _d16235846 |
||